The Department of Materials Science and Engineering at Stanford University is accepting applications for an Assistant Professor position.

Learn more.

BIND Biosciences recently announced that it has entered into an agreement with Amgen Inc. to develop and commercialize a kinase inhibitor nanomedicine for treating a range of tumors. The collaboration aims to create a nanomedicine with optimized therapeutic properties, applying tissue targeting to molecularly targeted drugs for the first time.

Learn more.

Read more Alliance in the News.

Gold Nanorods Detect Ovarian Cancer, Improve Surgical Removal in Mice

First-Of-Its-Kind Self-Assembled Nanoparticle for Targeted and Triggered Thermo-Chemotherapy

Shape Matters in DNA Nanoparticle Therapy

Nanoparticles Glow through Thick Layer of Tissue

Nanochains Mark Micrometastases for Early Diagnosis, Treatment

Nano-Enabled Paper Detects Kidney Cancer Markers

Enter your email below to receive news and updates:

	Watch a Video Journey Into the World of Nanotechnology in Cancer
	Discover how nanotechnology works and what it is. See animations of Nanowires, Cantilevers, and Nanoshells.
	Nanotechnology allows researchers to study cancer in its earliest stages of progression. Learn more about nanotechnology's impact on cancer.
	Read Alliance in the News to learn about recent advances in cancer nanotechnology

---

View our Image Library to see science at the nanoscale.